TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
TRAK

ReposiTrak

Technology · Software - Application · listed since 1998

8.50$ +3.0% vs. previous close Closing price · As of: Sep 17, 2026
🔔 Watch stock
Add to watchlist

Assessment

Our Rating

A journalistic assessment by our editorial team at the time of the deep dive — it rates the company, not the entry point. Not investment advice and not a solicitation to buy or sell.

Open questions

The business works in principle, but one material question is open. As long as it stays open, our findings do not carry a quality verdict.

Why this colour

Yellow, because the core business holds up — profitable, recurring revenue, almost no debt, no existential customer dependency — but a material operating question is open: whether the more than $8 million committed to the SPAR Group stake and its related loan turns out to be a smart strategic extension, or capital tied up exactly when a revenue-shrinking customer carrying two open Nasdaq deficiency notices needed extra liquidity most — one that actually got kicked off Nasdaq three days after ReposiTrak's own disclosure. Red would require more evidence — ReposiTrak itself reports no going-concern flag, no negative equity, and no signs of payment distress. Green would require more reliability: an unquantified, thinly explained capital decision in the exact quarter of the first revenue decline in nine quarters, and a communication pattern of announcing big numbers that quietly disappear later, both warrant extra scrutiny. The decision is yours.

What the thesis turns on

Assessment: Opportunities & Risks

ReposiTrak is a solid, profitable SaaS business with a proven operating track record — but the past six months show a management team pouring millions into an unrelated, struggling stake at the exact moment its own growth streak stumbled for the first time. The balance sheet remains healthy; the communication around the new bet has so far been thin. Not investment advice.

Business model & track record

B2B SaaS with recurring revenue, a diversified customer base (no customer above 10 percent of revenue), and a proven track record: the compliance business was genuinely scaled to more than a hundred thousand connected locations in the past.

Growth momentum

After nine straight quarters of growth (5.4 to 16.3 percent), revenue declined slightly for the first time in the quarter ended March 31, 2026 (-0.5 percent). The regulatory driver, FSMA 204, was delayed 30 months to July 2028 in March 2025.

Balance sheet & earnings quality

Cash and equity are strong ($26.4 million and $50.5 million as of March 31, 2026), essentially no bank debt. At the same time, operating cash flow fell 13 percent over the first nine months of fiscal 2026 even as reported operating income rose 28 percent.

SPAR Group stake

More than $8 million flowed between March and July 2026 into shares of and a loan to SPAR Group, Inc. and its subsidiary — a customer that carried a Nasdaq deficiency notice since January 2026 and a second since April 2026, was downgraded from Nasdaq to the OTC market three days after ReposiTrak's 31.4 percent stake was disclosed, and itself reports declining revenue and only $2.9 million in cash. Partly financed through an unsecured promissory note.

Management communication

Four earnings calls reviewed (2024-2026) show a pattern: a specific $20 million growth figure from 2024 was replaced in 2025 by a far more modest range and then vanished from the narrative without ever being confirmed or walked back. The new SPAR Group bet repeats the shape: a big announcement followed by "too early for KPIs."

Control structure

CEO Randall K. Fields controls 34 percent of common stock; all officers/directors together roughly 40 percent (fiscal 2025 Form 10-K). That aligns incentives with shareholders but also lets large capital decisions proceed effectively without meaningful pushback.

Worth Noting

Naming note: the company was named Park City Group, Inc. until December 21, 2023 (same SEC CIK, 0000050471). Older references under that name concern the same company.

As-of dates: balance sheet and earnings figures come from the fiscal 2025 Form 10-K (filed September 29, 2025) and the Form 10-Q for the quarter ended March 31, 2026 (filed May 14, 2026). Price and valuation data are as of August 21-26, 2026.

The four earnings calls we reviewed come from SEC Exhibit 99.2 to the respective Form 8-K filings — ReposiTrak publishes full transcripts as part of its mandatory disclosures, so no third-party transcript source was needed.

Stock Watch

This analysis is as of August 29, 2026. Stock Watch will tell you what's changed at TRAK since then.

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Price history

Chart

Interactive price chart (TradingView).

52-week range: 7.20 $ to 17.80 $ · Last price: 8.50 $ (As of: September 17, 2026)

Key figures

Key figures at a glance

Every figure we hold for this stock, grouped by topic. The question mark next to a label explains what the number means.

Basics

Market Cap ?The value of the entire company on the market: share price times total shares outstanding. 0.2$B
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 18m
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 70.0%
Beta ?Volatility versus the overall market: 1 = moves like the market, 2 = twice as much, under 1 = calmer than the market. 0.8

Performance

Perf. 1M ?Price performance over the last month. -12.80%
Perf. 3M ?Price performance over the last 3 months. 29.20%
Perf. 6M ?Price performance over the last 6 months. -31.00%
YTD Performance (%) ?Price performance since the start of the year (Year to Date). -26.20%
52-Week-High Distance ?How far the price sits below its highest point over the last 52 weeks. 0% means the stock is at its year high. -57.6%
Perf. 1Y ?Price performance over the last 12 months. -50.05%
Perf. 3Y ?Price performance over the last 3 years. 0.49%
Perf. 5Y ?Price performance over the last 5 years. 61.97%
Perf. 10Y ?Price performance over the last 10 years. -28.40%
Perf. Since Inception ?Price performance since the first available trading day (11/18/1998) — with a complete history, that is since the IPO. 39.42%

Technical Indicators

MA 38 Days ?Moving average of the last 38 trading days: the smoothed price path. A price above it signals short-term strength. 8.30$
MA 50 Days ?Moving average of the last 50 trading days — the most widely watched medium-term trend line. 8.40$
MA 200 Days ?Moving average of the last 200 trading days — the dividing line between a long-term uptrend and downtrend. 9.50$
RSI (14) ?Relative Strength Index over 14 days, scale 0 to 100: above 70 counts as overbought, below 30 as oversold. A hint on timing, not a verdict on the company. 58.6
Volatility 30 Days ?Price swings over the last 30 trading days, annualized. The higher the value, the more the price fluctuates. 34.6%
Volatility 250 Days ?Price swings over the last 250 trading days (roughly one market year), annualized. 44.3%

Calculated from the price history · as of 09/18/2026

Valuation

P/E ?Price-to-earnings ratio: how many years of profit does the stock cost? The lower, the cheaper the valuation. No earnings means no P/E. 24.2
Forward P/E ?P/E based on expected earnings for the next 12 months instead of past earnings — analysts' bet on the future. 16.8
PEG ?P/E divided by expected earnings growth: puts valuation in relation to growth. Around 1 is considered fair, well above that is pricey. 0.7
P/B ?Price-to-book ratio: market value relative to book equity. 3.0
P/S ?Price-to-sales ratio: market value divided by annual sales. Important for companies that aren't (yet) profitable. 6.7
EV/EBITDA ?Enterprise value including debt (EV) relative to operating profit before depreciation and amortization (EBITDA) — more comparable than P/E because debt counts too. Extreme values arise when EBITDA is near zero. 12.7
Price/FCF ?Market value divided by free cash flow: how many years of freely available cash does the stock cost? More honest than P/E because cash flow is harder to dress up. 21.4

Profitability

Gross Margin ?Gross margin: what's left of sales after only direct production costs are deducted — the product's pricing power. 85.4%
EBIT Margin ?EBIT margin: operating profit as a percentage of sales — the earning power of the core business before interest and taxes.
Net Margin ?Net margin: what's left of sales as profit after ALL costs, interest, and taxes. 31.1%
Return on Equity ?Return on equity: how much profit does the company generate per year on shareholders' equity? 14.7%
Return on Assets ?Return on assets: how much profit the company generates from its total assets (equity and debt combined). 8.4%

Balance Sheet & Safety

Equity Ratio ?Equity ratio: equity as a share of total assets. The higher, the more resilient the balance sheet.
Debt/Equity ?Leverage ratio: financial debt divided by equity. Under 1 is generally seen as solid; negative values mean negative equity. 0.01
Altman Z″ ?Edward Altman's bankruptcy early-warning score. We use the Z″ variant, built from four balance-sheet ratios — it is designed for service companies and non-manufacturers and uses book value instead of market value. On that scale: below 1.1 = danger zone, 2.6 and up = safe zone, in between a grey area. Because the classic Altman Z is calculated differently, the two numbers are not directly comparable. The formula does not fit banks, insurers, or real-estate stocks. fortress balance sheet 14.51
Piotroski ?Balance-sheet health check by Joseph Piotroski: 9 yes/no criteria on profit, cash flow, leverage, and efficiency. 7+ is very solid, under 3 is a red flag. 6 out of 9

Growth

Sales Growth Last Quarter ?Sales growth in the most recently reported quarter versus the same quarter a year ago (YoY). -0.50%
EPS Growth Last Quarter ?Growth in earnings per share in the most recently reported quarter versus the same quarter a year ago (YoY). 0.00%
Sales Growth (Year) ?Sales growth in the last fiscal year versus the year before. 10.53%
Forward Sales Growth ?Sales growth analysts expect over the next 12 months — an estimate, not a guarantee. 10.12%
Forward EPS Growth ?Earnings-per-share growth analysts expect over the next 12 months — an estimate, not a guarantee.

Dividend

Dividend Yield ?Annual dividend divided by the current price: what percentage of your investment comes back as a payout each year. 0.96%
Dividend Per Share (TTM) ?Sum of dividends paid per share over the last 12 months. 0.08$
Payout Ratio ?Share of profit paid out as dividends. Over 100% means the company is paying out more than it earns — not sustainable long-term. 28.6%
Years Without a Cut ?How many years in a row the dividend hasn't been cut — a measure of reliability. 1Years
Increase Streak ?How many years in a row the dividend has been raised — the gold standard for dividend payers. 1Years

Quality & Screener

Stage ?Weinstein phases 1 through 4: 1 = basing, 2 = uptrend (the only buy phase), 3 = topping, 4 = downtrend. Measured against the 30-week line. 4
RS Rating ?Relative strength from 1 to 99: an RS of 95 means the stock has outperformed 95% of all stocks. 14
EPS Rating ?Earnings growth rating from 1 to 99 versus all stocks — high values mean above-average earnings growth. 42
Fundamental Rating ?Our own Fundamental Rating: 0 to 100 points with an A+ to F grade. 50 points is the average across the universe, 100 the best possible score. It scores growth, earnings surprises, analyst estimates, margins, cash flow, and balance-sheet safety — every stock percentile-ranked against all others. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below. B (62 out of 100)

Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.

Comparison

Industry comparison

The stock alongside the largest companies in the same group. The median row is the middle value of the companies shown above — not of the whole industry.

Industry: Software - Application

Industry comparison
Company Market cap ($B) P/E EV/EBITDA Gross Margin % EBIT Margin % Sales Growth (Year) % Perf. 1Y %
ReposiTrak TRAK 0.2 24.2 12.7 85.4 10.5 -50.1
Salesforce.com Inc CRM 194.7 24.2 14.3 77.3 21.8 9.6 1.1
Uber Technologies Inc UBER 144.3 18.9 19.7 40.8 14.6 18.3 -23.8
ServiceNow Inc NOW 138.5 82.3 40.2 74.8 13.3 20.9 -27.2
Snowflake Inc. SNOW 115.4 -76.6 67.0 -22.2 29.2 55.3
Automatic Data Processing Inc ADP 108.8 25.1 16.4 48.7 30.2 7.1 -3.0
Adobe Systems Incorporated ADBE 99.2 14.3 9.8 89.3 35.3 10.5 -30.2
Intuit Inc INTU 86.0 20.0 12.2 81.0 47.0 15.6 -52.2
Datadog Inc DDOG 84.3 631.8 268.8 79.5 0.8 27.7 75.8
Median of companies shown 108.8 24.2 14.3 77.3 18.2 15.6 -23.8

Based on the most recently reported figures. Only stocks from the same trading venue are lined up, so the market caps are counted in one currency. Compare in a chart →

Fiscal years

Annual Figures

Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.

Revenue, operating income and net income per fiscal year $M

Revenue Operating income Net income

2016 · Revenue: 14 $M 2016 · Operating income: 1 $M 2016 · Net income: 1 $M 2017 · Revenue: 19 $M 2017 · Operating income: 4 $M 2017 · Net income: 4 $M 2018 · Revenue: 22 $M 2018 · Operating income: 4 $M 2018 · Net income: 3 $M 2019 · Revenue: 21 $M 2019 · Operating income: 4 $M 2019 · Net income: 4 $M 2020 · Revenue: 20 $M 2020 · Operating income: 1 $M 2020 · Net income: 2 $M 2021 · Revenue: 21 $M 2021 · Operating income: 3 $M 2021 · Net income: 4 $M 2022 · Revenue: 18 $M 2022 · Operating income: 4 $M 2022 · Net income: 4 $M 2023 · Revenue: 19 $M 2023 · Operating income: 5 $M 2023 · Net income: 6 $M 2024 · Revenue: 20 $M 2024 · Operating income: 5 $M 2024 · Net income: 6 $M 2025 · Revenue: 23 $M 2025 · Operating income: 6 $M 2025 · Net income: 7 $M
2016201720182019202020212022202320242025
Annual Figures
Fiscal Year Revenue ($M) EBIT ($M) Net Income ($M) EPS ($) Operating Cash Flow ($M) Equity ($M) Total Assets ($M)
2016 14 1 1 0.03 1 31 39
2017 19 4 4 0.19 2 36 46
2018 22 4 3 0.17 2 40 49
2019 21 4 4 0.19 5 43 53
2020 20 1 2 0.08 4 43 53
2021 21 3 4 0.21 5 45 55
2022 18 4 4 0.21 6 43 49
2023 19 5 6 0.30 9 46 51
2024 20 5 6 0.31 7 47 52
2025 23 6 7 0.36 8 50 55

Quarters

Quarterly Figures

Each bar is one quarter, the last one is the most recent. Use the switch to step through the individual figures.

Revenue & Profit

Cash Flow

Balance Sheet

Margins

Per Share

Click the chart or tab into it, then use ← and → to step through the periods.

None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.

These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.

The figures could not be loaded right now.

Sales Per Quarter ($M)
2024: Q4 · 5.5 $M Q4 2025: Q1 · 5.9 $M Q1 2025: Q2 · 5.8 $M Q2 2025: Q3 · 6.0 $M Q3 2025: Q4 · 5.9 $M Q4 2026: Q1 · 5.9 $M Q1

Source: fundamental data

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2024: Q4 0.09 6.90 6 7.10 28.20 4 4
2025: Q1 0.11 26.80 6 16.30 33.20 1 1
2025: Q2 0.10 13.80 6 11.10 31.20 2 2
2025: Q3 0.10 9.30 6 9.70 30.50 2 2
2025: Q4 0.09 8.70 6 6.70 28.80 2 2
2026: Q1 0.11 1.00 6 -0.50 33.80 2 2

What Do These Terms Mean?

EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

Compare with other stocks →

Screening

Appears in These Scanners

This stock currently matches 3 of our scanner strategies — each hit links to the scanner.

Growth

Momentum & Trend

Research

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners

Outlook

Analysts & Price Target

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Consensus Sell 1 = Strong buy … 5 = Strong sell
Analyst Ratings 1
Price Target (average) 16.00$
Distance to price 88.2% The price target sits 88.2% above the current price.

Distribution of Recommendations

Strong Buy 0
Buy 1
Hold 0
Sell 0
Strong Sell 0

Estimates by Fiscal Year

Estimates by Fiscal Year
Fiscal Year EPS Estimate ($) EPS Range ($) Revenue Estimate ($M) Expected Growth Analysts
06/30/2027 0.43 0.43 – 0.43 26 1

Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.

Valuation

What is priced in?

Instead of guessing what the stock is worth, we turn the question around: what free cash flow growth has to happen for today’s market value to add up? The assumptions behind it can be moved.

Today’s market value implies roughly 8.4% growth in free cash flow per year over ten years (assumptions: discount rate 10.0%, terminal growth 2.5%).

What is priced in?
Free cash flow (last twelve months) $7.5M
Market cap $158.0M
Free cash flow in year ten $16.8M
Terminal value as a share of market value 56.1%

For comparison: over the past five years free cash flow grew by 18.8% per year.

It shows which assumption is built into today’s price, not whether that assumption will hold. Every assumption can be changed with the sliders; the figures move with them.

A simplified model calculation — not a forecast and not a recommendation.

AI classification

AI Rating

Uses AI

Maschinelles Lernen steckt als patent-angemeldete Fehlerkorrektur in der verkauften Traceability-Plattform und die Firma nennt sich seit Mai 2026 selbst „AI-powered“ — einen eigenständigen KI-Umsatz weisen die Filings aber nicht aus, der Geschäftsbericht (10-K) GJ2025 erwähnt KI mit keinem Wort.

View the full file — quotes, sources, reviewed filings
„The first patent-pending technology relates to the use of advanced algorithms and machine learning techniques to identify inconsistencies, omissions, and inaccuracies within traceability datasets and to automatically correct such errors in real time."

Die erste zum Patent angemeldete Technologie nutzt fortgeschrittene Algorithmen und Techniken des maschinellen Lernens, um Widersprüche, Auslassungen und Fehler in Rückverfolgbarkeits-Datensätzen zu erkennen und in Echtzeit automatisch zu korrigieren.

10-Q · 2026-05-14 · View SEC filing

„ReposiTrak (NYSE: TRAK), an AI-powered, integrated supply chain platform"

ReposiTrak (NYSE: TRAK), eine KI-gestützte, integrierte Lieferketten-Plattform

8-K (Anlage 99.1, Ergebnismitteilung) · 2026-05-18 · View SEC filing

„We use our artificial intelligence tools to do this. It's extraordinarily robust and has the advantage that it not only identifies the errors, but it's able to correct them without bothering the supplier that created the data in the first place."

Wir nutzen dafür unsere Werkzeuge der künstlichen Intelligenz. Das System ist außerordentlich robust und erkennt Fehler nicht nur, sondern korrigiert sie, ohne den Lieferanten zu behelligen, der die Daten ursprünglich erzeugt hat.

8-K (Anlage 99.2, Call-Mitschrift) · 2026-02-19 · View SEC filing

Filings Reviewed: 10-K 2025-09-29 · 10-Q 2026-05-14 · 10-Q 2026-02-17 · 10-Q 2025-11-13 · 10-Q 2025-05-15 · 10-K 2024-09-30

Rated on August 26, 2026 · How the Rating Is Built

Growth

Growth Score

Ten checks against the annual reports — each one passed counts a point.

9 of 10 Growth gem
  • Revenue grows by more than 15% a year over three years 7.8%
  • More than 10% revenue growth is expected for the coming year 10.1%
  • Share count grows by less than 3% a year -0.4%
  • Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 47.7%
  • Gross margin at 40% or higher and without meaningful erosion 83.7%
  • Goodwill from acquisitions does not grow faster than revenue 37.7%
  • Net debt below twice EBITDA 28 m net cash
  • Operating cash flow covers the profits of the last three years 6 m
  • Return on capital at 15% or higher, or up versus two years ago 12.5%
  • Insiders hold at least 10% or are net buyers 33.7%

A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail

Quality check

AAQS

8/10

The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).

  • Sales growth 10Y > 5% 5.5%
  • Exp. sales growth 3Y > 5% 15.0%
  • EBIT growth 10Y > 5% 27.7%
  • Exp. EBIT growth 3Y > 5% 17.9%
  • Net debt < 4x EBIT -4.5x
  • EBIT positive, 10Y straight 10
  • Max. EBIT decline < 50% 62.9%
  • Return on equity > 15% 24.5%
  • ROCE > 15% 12.5%
  • Expected return > 10% 24.2%

View stocks with the full AAQS score · Read the methodology at AlleAktien

Source: fundamental data

Insiders

Insider Transactions

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

Insider Transactions
Date Person Role Type Shares Price Value
Aug 18, 2026 Merrill John R CHIEF FINANCIAL OFFICER Other 75,000 0.00

View all insider transactions →

The company

About the Company

ReposiTrak, Inc., ein Software-as-a-Service-Anbieter, betreibt eine B2B-Plattform für E-Commerce, Compliance und Rückverfolgbarkeit sowie Supply-Chain-Management in Nordamerika.

Employees
69
Headquarters
Murray, UT
Address
5282 South Commerce Drive, 84107 Murray, United States
Phone
435 645 2000
IPO Date
11/19/1998
ISIN
US7002153044
Stock Split
1:50 on 08/11/2006

Management

Management
Name Title Birth Year
Randall K. Fields Co-Founder, Chairman, President, CEO, COO & Head of Sales 1947
John R. Merrill Chief Financial Officer 1970
Edward L. Clissold J.D. General Counsel & Corporate Secretary 1956
Jozef Jamrich Chief Technology Officer
Derek Hannum Chief Customer Officer
Joe Meherg Senior Vice President of Sales
Shaun Broadhead Vice President of Development
Rob Fink Investor Relations Professional

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Filings

Company Filings (8-K)

An 8-K is the filing a US company must use to disclose material events immediately — takeovers, changes at the top, major contracts or payment troubles, for instance. The links open the original document at the US Securities and Exchange Commission (SEC).

  • 08/18/2026 ReposiTrak, Inc. (TRAK): Entry into a Material Definitive Agreement; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Financial Statements and Exhibits SEC ↗
  • 07/08/2026 ReposiTrak, Inc. (TRAK): Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Other Events; Financial Statements and Exhibits SEC ↗

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?